Australia's most trusted
source of pharma news
Saturday, 27 April 2024
Posted 3 August 2022 PM
Respiratory disease experts are concerned that around three quarters of Aussies with asthma are being prescribed too much preventer medicine and urge that "more is not always better".
Australian guidelines recommend the consideration of stepping down the dose of therapy when asthma has been stable and well controlled for two-three months in adults, and six months in children.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.